Literature DB >> 10987508

CDw60: an antigen expressed in many normal tissues and in some tumours.

A Gocht1, A Gadatsch, G Rutter, B Kniep.   

Abstract

CDw60 is a recently described T-cell antigen, which functionally delivers a costimulatory signal in T-cell activation. In addition, CDw60 has been regarded as a melanoma-associated antigen. To date, only limited information exists on the distribution of CDw60 in other normal and pathologically altered tissues in human. In the present study, the expression of CDw60 was analysed immunohistologically in a large panel of formalin-fixed and paraffin-embedded normal and pathological human tissues. The antigen was detected in several normal tissues, such as epithelia of the reproductive system, exocrine and endocrine glands, glial cells and neurons of the central and peripheral nervous systems, and lymphoid cells. These showed different subcellular distribution patterns, i.e. (1) cell surface labelling of peripheral lymphocytes and lymphocytes of the lymph node and thymus, (2) diffuse cytosolic staining in lymphocytes, subpial glial processes, and the outer plexiform layer of the retina, (3) granular cytoplasmic staining associated with the Golgi apparatus in epithelial cells of certain endocrine and exocrine glands, of the ductus epididymis and deferens, neurons of the peripheral and central nervous system, and lymphocytes and megakaryocytes of the bone marrow. In exocrine glands, e.g. of the prostate and uterine corpus, CDw60-positive Golgi fields were located in the juxtaluminal cell compartment, thus reflecting a polarized distribution. In some malignant tumours, the neoplastic cells contained CDw60-immunolabelled Golgi complexes, which were disorderly distributed throughout the cytoplasm, thus reflecting a loss of epithelial polarity. Only in mammary carcinomas was abnormal cell surface labelling detected. A putative de novo expression of CDw60 was observed in pleomorphic adenoma and mucoepidermoid carcinoma of the parotid gland, seminoma, embryonal and teratocarcinoma of the testis, small cell carcinoma of the lung, and malignant melanoma. These results define the CDw60 determinant as a broadly distributed antigen within a large panel of normal human tissues. The antigen is also detectable in some previously undescribed benign and malignant tumours, which may give importance to CDw60 as a possible diagnostic marker.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987508     DOI: 10.1023/a:1004099406623

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  42 in total

1.  CDw 60 antibodies bind to acetylated forms of ganglioside GD3.

Authors:  B Kniep; J Peter-Katalinić; W Flegel; H Northoff; E P Rieber
Journal:  Biochem Biophys Res Commun       Date:  1992-09-30       Impact factor: 3.575

2.  Down-regulation of the expression of O-acetyl-GD3 by the O-acetylesterase cDNA in hamster melanoma cells: effects on cellular proliferation, differentiation, and melanogenesis.

Authors:  S Birklé; S Ren; A Slominski; G Zeng; L Gao; R K Yu
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

Review 3.  The formation of axonal pathways in developing cranial nerves.

Authors:  M Yamamoto; G Schwarting
Journal:  Neurosci Res       Date:  1991-09       Impact factor: 3.304

4.  Identification of disialosyl paragloboside and O-acetyldisialosyl paragloboside in cerebellum and embryonic cerebrum.

Authors:  D K Chou; S Flores; F B Jungalwala
Journal:  J Neurochem       Date:  1990-05       Impact factor: 5.372

5.  Granule cell induction of 9-O-acetyl gangliosides on cerebellar glia in microcultures.

Authors:  R Mendez-Otero; M Constantine-Paton
Journal:  Dev Biol       Date:  1990-04       Impact factor: 3.582

6.  Developmental regulation of ganglioside antigens recognized by the JONES antibody.

Authors:  B Schlosshauer; A S Blum; R Mendez-Otero; C J Barnstable; M Constantine-Paton
Journal:  J Neurosci       Date:  1988-02       Impact factor: 6.167

7.  Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen.

Authors:  D A Fox; J A Millard; L Kan; W S Zeldes; W Davis; J Higgs; F Emmrich; R W Kinne
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

8.  Association of glycosphingolipids with intermediate filaments of mesenchymal, epithelial, glial, and muscle cells.

Authors:  B K Gillard; L T Thurmon; D M Marcus
Journal:  Cell Motil Cytoskeleton       Date:  1992

9.  Inhibition of sphingolipid synthesis: effects on glycosphingolipid-GPI-anchored protein microdomains.

Authors:  A H Futerman
Journal:  Trends Cell Biol       Date:  1995-10       Impact factor: 20.808

10.  UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions.

Authors:  O Baadsgaard; P Tong; J T Elder; E R Hansen; V Ho; C Hammerberg; G Lange-Vejlsgaard; D A Fox; G Fisher; L S Chan
Journal:  J Invest Dermatol       Date:  1990-09       Impact factor: 8.551

View more
  3 in total

1.  The role of 9-O-acetylated ganglioside D3 (CD60) and {alpha}4{beta}1 (CD49d) expression in predicting the survival of patients with Sezary syndrome.

Authors:  Enrico Scala; Damiano Abeni; Debora Pomponi; Maria Grazia Narducci; Giuseppe Alfonso Lombardo; Adriano Mari; Marina Frontani; Maria Cristina Picchio; Maria Antonietta Pilla; Elisabetta Caprini; Giandomenico Russo
Journal:  Haematologica       Date:  2010-07-27       Impact factor: 9.941

Review 2.  Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin.

Authors:  Guido Kohla; Eggert Stockfleth; Roland Schauer
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

3.  Acetylation suppresses the proapoptotic activity of GD3 ganglioside.

Authors:  Florence Malisan; Luigi Franchi; Barbara Tomassini; Natascia Ventura; Ivano Condò; Maria Rita Rippo; Alessandra Rufini; Laura Liberati; Claudia Nachtigall; Bernhard Kniep; Roberto Testi
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.